PharmAust subsidiary Epichem has entered into a joint venture deal to develop a “disruptive” waste-to-fuels technology using biomass and feedstock. Under the 50:50 agreement, medicinal and synthetic chemistry group Epichem and new JV partner Obsidian Minerals will set up the Perren company with the aim of developing and commercialising the biomass/feedstock oxidative hydrothermal dissolution chemical process that can turn waste into fuels.
02/09/2020 - 09:35
PharmAust subsidiary Epichem in waste-to-fuels tilt
By Matt Birney
02/09/2020 - 09:35
Related Data & Insights
-
-
Rank Company Revenue 128th PharmAust $3.8m 137th Adisyn $2.9m 138th rent.com.au $2.8m 141st Douugh $2.5m 142nd Hazer Group $2.4m 201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Mentioned People
Related Articles
05 Feb 2024
Board Moves February 5, 2024
03 Nov 2023
Appointments November 3, 2023
28 Aug 2023
Board Moves August 28, 2023
04 Feb 2022
Board Moves February 4, 2022
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX